nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—TXN—glaucoma	0.0156	0.108	CbGpPWpGaD
Clofarabine—RRM2—Synthesis and interconversion of nucleotide di- and triphosphates—TXN—glaucoma	0.0128	0.0886	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00636	0.0439	CbGpPWpGaD
Clofarabine—RRM1—Nucleotide metabolism—TXN—glaucoma	0.00482	0.0333	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00419	0.0289	CbGpPWpGaD
Clofarabine—RRM2—Nucleotide metabolism—TXN—glaucoma	0.00397	0.0274	CbGpPWpGaD
Clofarabine—DCK—Nucleotide metabolism—TXN—glaucoma	0.00371	0.0256	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00358	0.0247	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00345	0.0238	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00178	0.0123	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—glaucoma	0.00159	0.011	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—CDKN2A—glaucoma	0.00151	0.0104	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCND2—glaucoma	0.00149	0.0103	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.00146	0.0101	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CA5A—glaucoma	0.00139	0.00961	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NARFL—glaucoma	0.00139	0.00961	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RAB8A—glaucoma	0.00137	0.00946	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—CDKN1B—glaucoma	0.00134	0.00925	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.00133	0.0092	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00133	0.00919	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—glaucoma	0.00131	0.00904	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—FGFR1OP—glaucoma	0.0013	0.00899	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00129	0.0089	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CDKN2A—glaucoma	0.00125	0.0086	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.00123	0.00846	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RAB8A—glaucoma	0.00122	0.00845	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.00122	0.00841	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—OPTN—glaucoma	0.00119	0.0082	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.00116	0.00804	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NARFL—glaucoma	0.00115	0.00791	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CA5A—glaucoma	0.00115	0.00791	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CDKN1B—glaucoma	0.0011	0.00762	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NARFL—glaucoma	0.00107	0.00739	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CA5A—glaucoma	0.00107	0.00739	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—OPTN—glaucoma	0.00106	0.00733	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.00104	0.0072	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND2—glaucoma	0.00102	0.00702	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.001	0.00694	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000996	0.00688	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000959	0.00662	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000936	0.00647	CbGpPWpGaD
Clofarabine—Erythema—Clonidine—glaucoma	0.000931	0.00109	CcSEcCtD
Clofarabine—Tachycardia—Pilocarpine—glaucoma	0.000929	0.00109	CcSEcCtD
Clofarabine—Hypotension—Brinzolamide—glaucoma	0.000925	0.00108	CcSEcCtD
Clofarabine—Hyperhidrosis—Pilocarpine—glaucoma	0.00092	0.00108	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000918	0.00107	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Travoprost—glaucoma	0.000914	0.00107	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000911	0.00629	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000911	0.00106	CcSEcCtD
Clofarabine—Fatigue—Brimonidine—glaucoma	0.000909	0.00106	CcSEcCtD
Clofarabine—Anorexia—Pilocarpine—glaucoma	0.000907	0.00106	CcSEcCtD
Clofarabine—Feeling abnormal—Acetazolamide—glaucoma	0.000906	0.00106	CcSEcCtD
Clofarabine—Hypersensitivity—Apraclonidine—glaucoma	0.000905	0.00106	CcSEcCtD
Clofarabine—Paraesthesia—Dorzolamide—glaucoma	0.000904	0.00106	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000902	0.00105	CcSEcCtD
Clofarabine—Pain—Brimonidine—glaucoma	0.000902	0.00105	CcSEcCtD
Clofarabine—Dyspnoea—Dorzolamide—glaucoma	0.000898	0.00105	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000896	0.00619	CbGpPWpGaD
Clofarabine—Somnolence—Dorzolamide—glaucoma	0.000895	0.00105	CcSEcCtD
Clofarabine—Dyspnoea—Travoprost—glaucoma	0.000894	0.00105	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000891	0.00616	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—FGFR1OP—glaucoma	0.00089	0.00615	CbGpPWpGaD
Clofarabine—Hypotension—Pilocarpine—glaucoma	0.000889	0.00104	CcSEcCtD
Clofarabine—Paraesthesia—Brinzolamide—glaucoma	0.000889	0.00104	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Timolol—glaucoma	0.000884	0.00103	CcSEcCtD
Clofarabine—Dyspnoea—Brinzolamide—glaucoma	0.000883	0.00103	CcSEcCtD
Clofarabine—Asthenia—Apraclonidine—glaucoma	0.000881	0.00103	CcSEcCtD
Clofarabine—Somnolence—Brinzolamide—glaucoma	0.00088	0.00103	CcSEcCtD
Clofarabine—Decreased appetite—Dorzolamide—glaucoma	0.000876	0.00102	CcSEcCtD
Clofarabine—Tremor—Clonidine—glaucoma	0.000873	0.00102	CcSEcCtD
Clofarabine—Pruritus—Apraclonidine—glaucoma	0.000869	0.00102	CcSEcCtD
Clofarabine—Body temperature increased—Acetazolamide—glaucoma	0.000869	0.00102	CcSEcCtD
Clofarabine—Fatigue—Dorzolamide—glaucoma	0.000868	0.00102	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000867	0.00101	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Travoprost—glaucoma	0.000866	0.00101	CcSEcCtD
Clofarabine—Fatigue—Travoprost—glaucoma	0.000865	0.00101	CcSEcCtD
Clofarabine—Cardiac disorder—Betaxolol—glaucoma	0.000864	0.00101	CcSEcCtD
Clofarabine—Flushing—Betaxolol—glaucoma	0.000864	0.00101	CcSEcCtD
Clofarabine—Pain—Dorzolamide—glaucoma	0.000861	0.00101	CcSEcCtD
Clofarabine—Decreased appetite—Brinzolamide—glaucoma	0.000861	0.00101	CcSEcCtD
Clofarabine—Weight decreased—Timolol—glaucoma	0.00086	0.00101	CcSEcCtD
Clofarabine—Pain—Travoprost—glaucoma	0.000858	0.001	CcSEcCtD
Clofarabine—Agitation—Clonidine—glaucoma	0.000856	0.001	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000855	0.001	CcSEcCtD
Clofarabine—Paraesthesia—Pilocarpine—glaucoma	0.000855	0.000999	CcSEcCtD
Clofarabine—Asthenia—Bimatoprost—glaucoma	0.000855	0.000999	CcSEcCtD
Clofarabine—Fatigue—Brinzolamide—glaucoma	0.000854	0.000998	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—CDKN2A—glaucoma	0.000852	0.00589	CbGpPWpGaD
Clofarabine—Dyspnoea—Pilocarpine—glaucoma	0.000849	0.000992	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000847	0.00585	CbGpPWpGaD
Clofarabine—Pain—Brinzolamide—glaucoma	0.000847	0.00099	CcSEcCtD
Clofarabine—Somnolence—Pilocarpine—glaucoma	0.000846	0.000989	CcSEcCtD
Clofarabine—Angiopathy—Betaxolol—glaucoma	0.000845	0.000988	CcSEcCtD
Clofarabine—Pruritus—Bimatoprost—glaucoma	0.000843	0.000985	CcSEcCtD
Clofarabine—Immune system disorder—Betaxolol—glaucoma	0.000841	0.000984	CcSEcCtD
Clofarabine—Diarrhoea—Apraclonidine—glaucoma	0.000841	0.000983	CcSEcCtD
Clofarabine—Mediastinal disorder—Betaxolol—glaucoma	0.000839	0.000982	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—RAB8A—glaucoma	0.000837	0.00578	CbGpPWpGaD
Clofarabine—Chills—Betaxolol—glaucoma	0.000836	0.000977	CcSEcCtD
Clofarabine—Feeling abnormal—Dorzolamide—glaucoma	0.00083	0.000971	CcSEcCtD
Clofarabine—Decreased appetite—Pilocarpine—glaucoma	0.000827	0.000967	CcSEcCtD
Clofarabine—Feeling abnormal—Travoprost—glaucoma	0.000826	0.000966	CcSEcCtD
Clofarabine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000824	0.000963	CcSEcCtD
Clofarabine—Alopecia—Betaxolol—glaucoma	0.000823	0.000962	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000822	0.000961	CcSEcCtD
Clofarabine—Gastrointestinal pain—Travoprost—glaucoma	0.00082	0.000959	CcSEcCtD
Clofarabine—Feeling abnormal—Brinzolamide—glaucoma	0.000816	0.000954	CcSEcCtD
Clofarabine—Mental disorder—Betaxolol—glaucoma	0.000816	0.000954	CcSEcCtD
Clofarabine—Pain—Pilocarpine—glaucoma	0.000814	0.000952	CcSEcCtD
Clofarabine—Cough—Clonidine—glaucoma	0.000813	0.00095	CcSEcCtD
Clofarabine—Dizziness—Apraclonidine—glaucoma	0.000812	0.00095	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—OPTN—glaucoma	0.000812	0.00561	CbGpPWpGaD
Clofarabine—Erythema—Betaxolol—glaucoma	0.000811	0.000948	CcSEcCtD
Clofarabine—Malnutrition—Betaxolol—glaucoma	0.000811	0.000948	CcSEcCtD
Clofarabine—RRM2—G1/S Transition—CDKN1B—glaucoma	0.000801	0.00553	CbGpPWpGaD
Clofarabine—Epistaxis—Timolol—glaucoma	0.000799	0.000935	CcSEcCtD
Clofarabine—Abdominal pain—Dorzolamide—glaucoma	0.000796	0.000931	CcSEcCtD
Clofarabine—Body temperature increased—Dorzolamide—glaucoma	0.000796	0.000931	CcSEcCtD
Clofarabine—Sinusitis—Timolol—glaucoma	0.000795	0.00093	CcSEcCtD
Clofarabine—Arthralgia—Clonidine—glaucoma	0.000793	0.000927	CcSEcCtD
Clofarabine—Abdominal pain—Travoprost—glaucoma	0.000793	0.000927	CcSEcCtD
Clofarabine—Anxiety—Clonidine—glaucoma	0.00079	0.000924	CcSEcCtD
Clofarabine—Asthenia—Acetazolamide—glaucoma	0.000788	0.000922	CcSEcCtD
Clofarabine—Dizziness—Bimatoprost—glaucoma	0.000788	0.000921	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000787	0.000921	CcSEcCtD
Clofarabine—Feeling abnormal—Pilocarpine—glaucoma	0.000784	0.000917	CcSEcCtD
Clofarabine—Vomiting—Apraclonidine—glaucoma	0.000781	0.000913	CcSEcCtD
Clofarabine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000778	0.00091	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000778	0.00537	CbGpPWpGaD
Clofarabine—Hypersensitivity—Brimonidine—glaucoma	0.000777	0.000909	CcSEcCtD
Clofarabine—Dermatitis—Apraclonidine—glaucoma	0.000774	0.000905	CcSEcCtD
Clofarabine—Headache—Apraclonidine—glaucoma	0.00077	0.0009	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000762	0.00526	CbGpPWpGaD
Clofarabine—Oedema—Clonidine—glaucoma	0.00076	0.000889	CcSEcCtD
Clofarabine—Tremor—Betaxolol—glaucoma	0.00076	0.000888	CcSEcCtD
Clofarabine—Asthenia—Brimonidine—glaucoma	0.000757	0.000885	CcSEcCtD
Clofarabine—Infection—Clonidine—glaucoma	0.000755	0.000883	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—CDKN1B—glaucoma	0.000755	0.00521	CbGpPWpGaD
Clofarabine—Body temperature increased—Pilocarpine—glaucoma	0.000752	0.00088	CcSEcCtD
Clofarabine—Abdominal pain—Pilocarpine—glaucoma	0.000752	0.00088	CcSEcCtD
Clofarabine—Diarrhoea—Acetazolamide—glaucoma	0.000752	0.000879	CcSEcCtD
Clofarabine—Rash—Bimatoprost—glaucoma	0.000751	0.000878	CcSEcCtD
Clofarabine—Dermatitis—Bimatoprost—glaucoma	0.00075	0.000877	CcSEcCtD
Clofarabine—Oedema peripheral—Timolol—glaucoma	0.00075	0.000876	CcSEcCtD
Clofarabine—Anaemia—Betaxolol—glaucoma	0.000749	0.000876	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000749	0.00517	CbGpPWpGaD
Clofarabine—Connective tissue disorder—Timolol—glaucoma	0.000748	0.000874	CcSEcCtD
Clofarabine—Pruritus—Brimonidine—glaucoma	0.000746	0.000873	CcSEcCtD
Clofarabine—Headache—Bimatoprost—glaucoma	0.000746	0.000873	CcSEcCtD
Clofarabine—Nervous system disorder—Clonidine—glaucoma	0.000745	0.000872	CcSEcCtD
Clofarabine—Thrombocytopenia—Clonidine—glaucoma	0.000744	0.00087	CcSEcCtD
Clofarabine—Hypersensitivity—Dorzolamide—glaucoma	0.000742	0.000868	CcSEcCtD
Clofarabine—Tachycardia—Clonidine—glaucoma	0.000742	0.000867	CcSEcCtD
Clofarabine—Hypersensitivity—Travoprost—glaucoma	0.000739	0.000864	CcSEcCtD
Clofarabine—Skin disorder—Clonidine—glaucoma	0.000738	0.000863	CcSEcCtD
Clofarabine—Hyperhidrosis—Clonidine—glaucoma	0.000735	0.000859	CcSEcCtD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000732	0.00505	CbGpPWpGaD
Clofarabine—Nausea—Apraclonidine—glaucoma	0.00073	0.000853	CcSEcCtD
Clofarabine—Hypersensitivity—Brinzolamide—glaucoma	0.00073	0.000853	CcSEcCtD
Clofarabine—Dizziness—Acetazolamide—glaucoma	0.000727	0.00085	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—OPTN—glaucoma	0.000726	0.00501	CbGpPWpGaD
Clofarabine—Anorexia—Clonidine—glaucoma	0.000725	0.000847	CcSEcCtD
Clofarabine—Asthenia—Dorzolamide—glaucoma	0.000723	0.000845	CcSEcCtD
Clofarabine—Asthenia—Travoprost—glaucoma	0.00072	0.000841	CcSEcCtD
Clofarabine—Pruritus—Dorzolamide—glaucoma	0.000713	0.000833	CcSEcCtD
Clofarabine—Asthenia—Brinzolamide—glaucoma	0.000711	0.000831	CcSEcCtD
Clofarabine—Hypotension—Clonidine—glaucoma	0.00071	0.00083	CcSEcCtD
Clofarabine—Pruritus—Travoprost—glaucoma	0.00071	0.00083	CcSEcCtD
Clofarabine—Cough—Betaxolol—glaucoma	0.000708	0.000827	CcSEcCtD
Clofarabine—Nausea—Bimatoprost—glaucoma	0.000708	0.000827	CcSEcCtD
Clofarabine—Cardiac disorder—Timolol—glaucoma	0.000706	0.000826	CcSEcCtD
Clofarabine—Hypersensitivity—Pilocarpine—glaucoma	0.000701	0.00082	CcSEcCtD
Clofarabine—Pruritus—Brinzolamide—glaucoma	0.000701	0.000819	CcSEcCtD
Clofarabine—Vomiting—Acetazolamide—glaucoma	0.000699	0.000817	CcSEcCtD
Clofarabine—Dizziness—Brimonidine—glaucoma	0.000697	0.000816	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000693	0.00081	CcSEcCtD
Clofarabine—Angiopathy—Timolol—glaucoma	0.00069	0.000807	CcSEcCtD
Clofarabine—Myalgia—Betaxolol—glaucoma	0.00069	0.000807	CcSEcCtD
Clofarabine—Arthralgia—Betaxolol—glaucoma	0.00069	0.000807	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.00069	0.00477	CbGpPWpGaD
Clofarabine—Diarrhoea—Dorzolamide—glaucoma	0.000689	0.000806	CcSEcCtD
Clofarabine—Headache—Acetazolamide—glaucoma	0.000688	0.000805	CcSEcCtD
Clofarabine—Anxiety—Betaxolol—glaucoma	0.000688	0.000804	CcSEcCtD
Clofarabine—Immune system disorder—Timolol—glaucoma	0.000687	0.000804	CcSEcCtD
Clofarabine—Diarrhoea—Travoprost—glaucoma	0.000686	0.000802	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000686	0.00474	CbGpPWpGaD
Clofarabine—Mediastinal disorder—Timolol—glaucoma	0.000686	0.000802	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000686	0.000802	CcSEcCtD
Clofarabine—Asthenia—Pilocarpine—glaucoma	0.000683	0.000799	CcSEcCtD
Clofarabine—Paraesthesia—Clonidine—glaucoma	0.000683	0.000798	CcSEcCtD
Clofarabine—RRM1—Metabolism—CA1—glaucoma	0.000679	0.00469	CbGpPWpGaD
Clofarabine—Dyspnoea—Clonidine—glaucoma	0.000678	0.000792	CcSEcCtD
Clofarabine—Diarrhoea—Brinzolamide—glaucoma	0.000678	0.000792	CcSEcCtD
Clofarabine—Somnolence—Clonidine—glaucoma	0.000676	0.00079	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000675	0.00466	CbGpPWpGaD
Clofarabine—Pruritus—Pilocarpine—glaucoma	0.000673	0.000787	CcSEcCtD
Clofarabine—Alopecia—Timolol—glaucoma	0.000672	0.000786	CcSEcCtD
Clofarabine—Mental disorder—Timolol—glaucoma	0.000667	0.000779	CcSEcCtD
Clofarabine—Dizziness—Dorzolamide—glaucoma	0.000666	0.000779	CcSEcCtD
Clofarabine—Rash—Brimonidine—glaucoma	0.000665	0.000778	CcSEcCtD
Clofarabine—Dermatitis—Brimonidine—glaucoma	0.000664	0.000777	CcSEcCtD
Clofarabine—Dizziness—Travoprost—glaucoma	0.000663	0.000776	CcSEcCtD
Clofarabine—Malnutrition—Timolol—glaucoma	0.000662	0.000775	CcSEcCtD
Clofarabine—Erythema—Timolol—glaucoma	0.000662	0.000775	CcSEcCtD
Clofarabine—Oedema—Betaxolol—glaucoma	0.000662	0.000774	CcSEcCtD
Clofarabine—Headache—Brimonidine—glaucoma	0.000661	0.000773	CcSEcCtD
Clofarabine—Decreased appetite—Clonidine—glaucoma	0.000661	0.000773	CcSEcCtD
Clofarabine—RRM1—Metabolism—CTSA—glaucoma	0.000658	0.00454	CbGpPWpGaD
Clofarabine—Infection—Betaxolol—glaucoma	0.000657	0.000769	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Clonidine—glaucoma	0.000656	0.000767	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000656	0.00453	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000655	0.00453	CbGpPWpGaD
Clofarabine—Fatigue—Clonidine—glaucoma	0.000655	0.000766	CcSEcCtD
Clofarabine—Dizziness—Brinzolamide—glaucoma	0.000655	0.000766	CcSEcCtD
Clofarabine—Nausea—Acetazolamide—glaucoma	0.000653	0.000763	CcSEcCtD
Clofarabine—Diarrhoea—Pilocarpine—glaucoma	0.000651	0.000761	CcSEcCtD
Clofarabine—Pain—Clonidine—glaucoma	0.00065	0.00076	CcSEcCtD
Clofarabine—Nervous system disorder—Betaxolol—glaucoma	0.000649	0.000759	CcSEcCtD
Clofarabine—Thrombocytopenia—Betaxolol—glaucoma	0.000648	0.000758	CcSEcCtD
Clofarabine—Tachycardia—Betaxolol—glaucoma	0.000646	0.000755	CcSEcCtD
Clofarabine—Skin disorder—Betaxolol—glaucoma	0.000643	0.000752	CcSEcCtD
Clofarabine—Vomiting—Dorzolamide—glaucoma	0.00064	0.000749	CcSEcCtD
Clofarabine—Hyperhidrosis—Betaxolol—glaucoma	0.00064	0.000748	CcSEcCtD
Clofarabine—Rash—Dorzolamide—glaucoma	0.000635	0.000743	CcSEcCtD
Clofarabine—Dermatitis—Dorzolamide—glaucoma	0.000635	0.000742	CcSEcCtD
Clofarabine—Rash—Travoprost—glaucoma	0.000632	0.000739	CcSEcCtD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—glaucoma	0.000632	0.00437	CbGpPWpGaD
Clofarabine—Dermatitis—Travoprost—glaucoma	0.000632	0.000739	CcSEcCtD
Clofarabine—Headache—Dorzolamide—glaucoma	0.000631	0.000738	CcSEcCtD
Clofarabine—Anorexia—Betaxolol—glaucoma	0.000631	0.000738	CcSEcCtD
Clofarabine—Vomiting—Brinzolamide—glaucoma	0.00063	0.000736	CcSEcCtD
Clofarabine—Dizziness—Pilocarpine—glaucoma	0.000629	0.000736	CcSEcCtD
Clofarabine—Headache—Travoprost—glaucoma	0.000628	0.000735	CcSEcCtD
Clofarabine—Nausea—Brimonidine—glaucoma	0.000627	0.000733	CcSEcCtD
Clofarabine—Feeling abnormal—Clonidine—glaucoma	0.000626	0.000732	CcSEcCtD
Clofarabine—Rash—Brinzolamide—glaucoma	0.000624	0.00073	CcSEcCtD
Clofarabine—Dermatitis—Brinzolamide—glaucoma	0.000624	0.000729	CcSEcCtD
Clofarabine—Gastrointestinal pain—Clonidine—glaucoma	0.000622	0.000727	CcSEcCtD
Clofarabine—RRM1—Metabolism—CA2—glaucoma	0.000621	0.00429	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000621	0.00429	CbGpPWpGaD
Clofarabine—Headache—Brinzolamide—glaucoma	0.00062	0.000725	CcSEcCtD
Clofarabine—Hypotension—Betaxolol—glaucoma	0.000618	0.000723	CcSEcCtD
Clofarabine—POLA1—Synthesis of DNA—CDKN1B—glaucoma	0.000606	0.00419	CbGpPWpGaD
Clofarabine—Vomiting—Pilocarpine—glaucoma	0.000605	0.000708	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000603	0.000705	CcSEcCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000603	0.00416	CbGpPWpGaD
Clofarabine—Body temperature increased—Clonidine—glaucoma	0.000601	0.000703	CcSEcCtD
Clofarabine—Abdominal pain—Clonidine—glaucoma	0.000601	0.000703	CcSEcCtD
Clofarabine—Rash—Pilocarpine—glaucoma	0.0006	0.000702	CcSEcCtD
Clofarabine—Dermatitis—Pilocarpine—glaucoma	0.0006	0.000701	CcSEcCtD
Clofarabine—Nausea—Dorzolamide—glaucoma	0.000598	0.0007	CcSEcCtD
Clofarabine—Headache—Pilocarpine—glaucoma	0.000596	0.000697	CcSEcCtD
Clofarabine—Nausea—Travoprost—glaucoma	0.000596	0.000697	CcSEcCtD
Clofarabine—Paraesthesia—Betaxolol—glaucoma	0.000594	0.000695	CcSEcCtD
Clofarabine—Dyspnoea—Betaxolol—glaucoma	0.00059	0.00069	CcSEcCtD
Clofarabine—Nausea—Brinzolamide—glaucoma	0.000588	0.000688	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000587	0.00405	CbGpPWpGaD
Clofarabine—Cough—Timolol—glaucoma	0.000578	0.000676	CcSEcCtD
Clofarabine—Decreased appetite—Betaxolol—glaucoma	0.000575	0.000673	CcSEcCtD
Clofarabine—Hypertension—Timolol—glaucoma	0.000572	0.000669	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000571	0.000668	CcSEcCtD
Clofarabine—Fatigue—Betaxolol—glaucoma	0.000571	0.000667	CcSEcCtD
Clofarabine—POLA1—DNA Replication—CDKN1B—glaucoma	0.000569	0.00393	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000568	0.00392	CbGpPWpGaD
Clofarabine—Pain—Betaxolol—glaucoma	0.000566	0.000662	CcSEcCtD
Clofarabine—Nausea—Pilocarpine—glaucoma	0.000565	0.000661	CcSEcCtD
Clofarabine—Myalgia—Timolol—glaucoma	0.000564	0.000659	CcSEcCtD
Clofarabine—Arthralgia—Timolol—glaucoma	0.000564	0.000659	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000563	0.00389	CbGpPWpGaD
Clofarabine—Anxiety—Timolol—glaucoma	0.000562	0.000657	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00056	0.000655	CcSEcCtD
Clofarabine—Hypersensitivity—Clonidine—glaucoma	0.00056	0.000655	CcSEcCtD
Clofarabine—RRM2—Metabolism—CA1—glaucoma	0.000559	0.00386	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—CDKN1B—glaucoma	0.000548	0.00378	CbGpPWpGaD
Clofarabine—Asthenia—Clonidine—glaucoma	0.000545	0.000638	CcSEcCtD
Clofarabine—Feeling abnormal—Betaxolol—glaucoma	0.000545	0.000638	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND2—glaucoma	0.000545	0.00376	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CTSA—glaucoma	0.000542	0.00374	CbGpPWpGaD
Clofarabine—Oedema—Timolol—glaucoma	0.000541	0.000632	CcSEcCtD
Clofarabine—Pruritus—Clonidine—glaucoma	0.000538	0.000629	CcSEcCtD
Clofarabine—Infection—Timolol—glaucoma	0.000537	0.000628	CcSEcCtD
Clofarabine—Nervous system disorder—Timolol—glaucoma	0.00053	0.00062	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000525	0.00363	CbGpPWpGaD
Clofarabine—Skin disorder—Timolol—glaucoma	0.000525	0.000614	CcSEcCtD
Clofarabine—Body temperature increased—Betaxolol—glaucoma	0.000523	0.000612	CcSEcCtD
Clofarabine—DCK—Metabolism—CA1—glaucoma	0.000523	0.00361	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Timolol—glaucoma	0.000523	0.000611	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000521	0.0036	CbGpPWpGaD
Clofarabine—Diarrhoea—Clonidine—glaucoma	0.00052	0.000608	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000516	0.00357	CbGpPWpGaD
Clofarabine—Anorexia—Timolol—glaucoma	0.000515	0.000603	CcSEcCtD
Clofarabine—RRM2—Metabolism—CA2—glaucoma	0.000512	0.00353	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CTSA—glaucoma	0.000506	0.0035	CbGpPWpGaD
Clofarabine—Hypotension—Timolol—glaucoma	0.000505	0.000591	CcSEcCtD
Clofarabine—Dizziness—Clonidine—glaucoma	0.000503	0.000588	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000502	0.00347	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CDKN1B—glaucoma	0.000497	0.00343	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Timolol—glaucoma	0.000493	0.000576	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—glaucoma	0.000489	0.00338	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000489	0.00337	CbGpPWpGaD
Clofarabine—Hypersensitivity—Betaxolol—glaucoma	0.000488	0.00057	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CCND2—glaucoma	0.000487	0.00337	CbGpPWpGaD
Clofarabine—Paraesthesia—Timolol—glaucoma	0.000485	0.000568	CcSEcCtD
Clofarabine—Vomiting—Clonidine—glaucoma	0.000483	0.000565	CcSEcCtD
Clofarabine—Dyspnoea—Timolol—glaucoma	0.000482	0.000564	CcSEcCtD
Clofarabine—Somnolence—Timolol—glaucoma	0.000481	0.000562	CcSEcCtD
Clofarabine—Rash—Clonidine—glaucoma	0.000479	0.00056	CcSEcCtD
Clofarabine—Dermatitis—Clonidine—glaucoma	0.000479	0.00056	CcSEcCtD
Clofarabine—DCK—Metabolism—CA2—glaucoma	0.000478	0.0033	CbGpPWpGaD
Clofarabine—Headache—Clonidine—glaucoma	0.000476	0.000557	CcSEcCtD
Clofarabine—Asthenia—Betaxolol—glaucoma	0.000475	0.000555	CcSEcCtD
Clofarabine—Decreased appetite—Timolol—glaucoma	0.00047	0.00055	CcSEcCtD
Clofarabine—Pruritus—Betaxolol—glaucoma	0.000468	0.000547	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Timolol—glaucoma	0.000467	0.000546	CcSEcCtD
Clofarabine—Fatigue—Timolol—glaucoma	0.000466	0.000545	CcSEcCtD
Clofarabine—Pain—Timolol—glaucoma	0.000462	0.000541	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000461	0.00319	CbGpPWpGaD
Clofarabine—Diarrhoea—Betaxolol—glaucoma	0.000453	0.000529	CcSEcCtD
Clofarabine—Nausea—Clonidine—glaucoma	0.000451	0.000528	CcSEcCtD
Clofarabine—Feeling abnormal—Timolol—glaucoma	0.000445	0.000521	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000442	0.00306	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Timolol—glaucoma	0.000442	0.000517	CcSEcCtD
Clofarabine—RRM1—Metabolism—TXN—glaucoma	0.000438	0.00302	CbGpPWpGaD
Clofarabine—Dizziness—Betaxolol—glaucoma	0.000438	0.000512	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDKN2B—glaucoma	0.000437	0.00302	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NARFL—glaucoma	0.000428	0.00296	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CA5A—glaucoma	0.000428	0.00296	CbGpPWpGaD
Clofarabine—Body temperature increased—Timolol—glaucoma	0.000427	0.0005	CcSEcCtD
Clofarabine—Abdominal pain—Timolol—glaucoma	0.000427	0.0005	CcSEcCtD
Clofarabine—Vomiting—Betaxolol—glaucoma	0.000421	0.000492	CcSEcCtD
Clofarabine—Rash—Betaxolol—glaucoma	0.000417	0.000488	CcSEcCtD
Clofarabine—Dermatitis—Betaxolol—glaucoma	0.000417	0.000487	CcSEcCtD
Clofarabine—Headache—Betaxolol—glaucoma	0.000415	0.000485	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000412	0.00285	CbGpPWpGaD
Clofarabine—Hypersensitivity—Timolol—glaucoma	0.000398	0.000466	CcSEcCtD
Clofarabine—Nausea—Betaxolol—glaucoma	0.000393	0.00046	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.00039	0.00269	CbGpPWpGaD
Clofarabine—Asthenia—Timolol—glaucoma	0.000388	0.000454	CcSEcCtD
Clofarabine—Pruritus—Timolol—glaucoma	0.000382	0.000447	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND2—glaucoma	0.000373	0.00257	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000372	0.00257	CbGpPWpGaD
Clofarabine—Diarrhoea—Timolol—glaucoma	0.00037	0.000433	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000369	0.00255	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—TXN—glaucoma	0.00036	0.00249	CbGpPWpGaD
Clofarabine—Dizziness—Timolol—glaucoma	0.000357	0.000418	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00035	0.00242	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.00035	0.00241	CbGpPWpGaD
Clofarabine—Vomiting—Timolol—glaucoma	0.000344	0.000402	CcSEcCtD
Clofarabine—Rash—Timolol—glaucoma	0.000341	0.000399	CcSEcCtD
Clofarabine—Dermatitis—Timolol—glaucoma	0.000341	0.000398	CcSEcCtD
Clofarabine—RRM1—Metabolism—GSTT1—glaucoma	0.000339	0.00234	CbGpPWpGaD
Clofarabine—Headache—Timolol—glaucoma	0.000339	0.000396	CcSEcCtD
Clofarabine—DCK—Metabolism—TXN—glaucoma	0.000337	0.00233	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000334	0.00231	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND2—glaucoma	0.000333	0.0023	CbGpPWpGaD
Clofarabine—Nausea—Timolol—glaucoma	0.000321	0.000375	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CDKN2B—glaucoma	0.000299	0.00206	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000291	0.00201	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTT1—glaucoma	0.000279	0.00193	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000279	0.00193	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP1B1—glaucoma	0.00027	0.00187	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ABCA1—glaucoma	0.00027	0.00187	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTT1—glaucoma	0.000261	0.0018	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000257	0.00177	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN2A—glaucoma	0.00025	0.00173	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000249	0.00172	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000247	0.00171	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ABCA1—glaucoma	0.000223	0.00154	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP1B1—glaucoma	0.000223	0.00154	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1B—glaucoma	0.000221	0.00153	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.00022	0.00152	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTM1—glaucoma	0.000216	0.00149	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CA1—glaucoma	0.000209	0.00144	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ABCA1—glaucoma	0.000208	0.00144	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP1B1—glaucoma	0.000208	0.00144	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CTSA—glaucoma	0.000203	0.0014	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CA2—glaucoma	0.000191	0.00132	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000191	0.00132	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—MTHFR—glaucoma	0.000191	0.00132	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTM1—glaucoma	0.000178	0.00123	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOE—glaucoma	0.000178	0.00123	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CAV1—glaucoma	0.000176	0.00122	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2A—glaucoma	0.000171	0.00118	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000169	0.00117	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTM1—glaucoma	0.000166	0.00115	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—MTHFR—glaucoma	0.000157	0.00109	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1B—glaucoma	0.000151	0.00105	CbGpPWpGaD
Clofarabine—DCK—Metabolism—MTHFR—glaucoma	0.000147	0.00102	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APOE—glaucoma	0.000146	0.00101	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CAV1—glaucoma	0.000145	0.001	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—glaucoma	0.000139	0.00096	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOE—glaucoma	0.000137	0.000945	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CAV1—glaucoma	0.000136	0.000937	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TXN—glaucoma	0.000135	0.000931	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NOS3—glaucoma	0.000133	0.00092	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—glaucoma	0.000122	0.000842	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NOS3—glaucoma	0.00011	0.000758	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTT1—glaucoma	0.000105	0.000722	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NOS3—glaucoma	0.000103	0.000708	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—glaucoma	0.0001	0.000693	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—glaucoma	9.51e-05	0.000657	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—glaucoma	9.38e-05	0.000648	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCA1—glaucoma	8.33e-05	0.000575	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP1B1—glaucoma	8.33e-05	0.000575	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTM1—glaucoma	6.66e-05	0.00046	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTHFR—glaucoma	5.88e-05	0.000406	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOE—glaucoma	5.48e-05	0.000378	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CAV1—glaucoma	5.43e-05	0.000375	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NOS3—glaucoma	4.1e-05	0.000283	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—glaucoma	3.75e-05	0.000259	CbGpPWpGaD
